Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas

Oncology Reports

Volumn 19, Issue 6, 2008, Pages 1435-1443

  Sanada, Yuichi ^a,b   Kunita, Satoko ^a   Yoshida, Kazuhiro ^b  

^a Saiseikai Kure Hospital   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Intraductal papillary mucinous carcinoma; Mucin 2; Orotate phosphoribosyltransferase; Subtype

Indexed keywords

MUCIN 2; OROTATE PHOSPHORIBOSYLTRANSFERASE; MUCIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CARCINOMA IN SITU; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; METASTASIS POTENTIAL; MICROSCOPY; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; ADENOMA; CANCER STAGING; CASE REPORT; CELL TRANSFORMATION; CLASSIFICATION; ENZYME IMMUNOASSAY; IMMUNOLOGY; INTESTINE TUMOR; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS;

ADENOMA; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; MUCINS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OROTATE PHOSPHORIBOSYLTRANSFERASE; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 48849087978     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Furukawa T, Kloppel G, Adsay NV, Albores-Saavedra J, Fukushima N, et al: Classification of types of intraductal papillary-mucinous neoplasm of the pancreas. Virchows Arch 447: 794-799, 2005.
2. Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, et al: Pathologically distinct types of epithelium in intraductal papillary mucinous neoplasms. Delineation of an intestinal pathway of carcinogenesis in the pancreas. Am J Surg Pathol 28: 839-848, 2004.
3. Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, et al: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 30: 1561-1569, 2006.
4. Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, et al: Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 34: 197-204, 2007.
5. Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, et al: New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol 197: 201-210, 2002.
6. Ban S, Naitoh Y, Ogawa F, Shimizu Y, Shimizu M, et al: Intraductal papillary mucinous neoplasm (IPMN) of the gastric-type with focal nodular growth of the arborizing papillae: a case of high-grade transformation of the gastric-type IPMN. Virchows Arch 449: 112-116, 2006.
7. Sanada Y, Yoshida K, Ohara M and Tsutani Y: Expression of Orotate phosphoribosyltransferase (OPRT) in hepatobiliary and pancreatic carcinoma. Pathol Oncol Res 13: 105-113, 2007.
8. Sanada. Y and Yoshida K: Immunohistochemical analyses in intraductal gradually transitional components is useful for evaluation of stepwise, progression of pancreatic intraepithelial neoplasia. Pancreas 35: 101-103, 2007.
9. Takaori K: Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg 14: 217-223, 2007.
10. Cuillerier E, Cellier C, Palazzo L, Deviere J, Wind P, et al: Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 95: 441-445, 2000.
11. Marie F, Hammel P, Terris B, Paye F, Scoazec J-Y, et al: Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 51: 717-722, 2002.
12. Angerica MD, Brennan MF, Suriawinata AA, Klimstra D and Conlon KC: Intraductal papillary mucinous neoplasms of the pancreas. An analysis of clinicopathologic features and outcome. Ann Surg 239: 400-408, 2004.
13. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, et al: Intraductal papillary mucinous neoplasms of the pancreas. An update experience. Ann Surg 239: 788-799, 2004.
14. Nagata, K, Horinouchi M, Saitou M, Higashi M, Nomoto M, et al: Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg 14: 243-254, 2007.
15. Adsay NV, Conlon KC, Zee SY, Brennan MF and Klimstra, DS: Intraductal papillary-mucinous neoplasms of the pancreas. An analysis of in situ and invasive carcinomas in 28 patients. Cancer 94: 62-77, 2002.
16. Pelaez-Luna M, Chari ST, Smyrk TC, Takahashi N, Clain JE, et al: Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 102: 1759-1764, 2007.
17. Tanase H, Suda K, Yamasaki S and Nobukawa B: Intraductal low papillary histological pattern of carcinoma component shows intraductal, spread in invasive carcinoma of the pancreas. J Hepatobiliary Pancreat Surg 13: 235-239, 2006.
18. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garret ES, et al: Pancreatic intraepithelial neoplasia; a new classification system for pancreatic duct lesions. Am J Surg Pathol 25: 579-586, 2001.
19. Albores-Saavedra J, Wu J, Crook T, Amirkhan RH, Jones L, et al: Intestinal and oncocytic variants of pancreatic intraepithelial neoplasia. A morphological and immunohistochemical study. Ann Diagn Pathol 9: 69-76, 2005.